Product Information
OFLOXACIN 0.3% EAR DROPS is a generic product labeled by Leading Pharma, LLC, priced at $1.1098 per ML under NDC 69315032005. Its NADAC has been published 122 times since Jun 5, 2024.
FDA first approved this application on Jan 5, 2024. Its Orange Book therapeutic-equivalence code is AT.
Strength
3 mg/mL
Manufacturer
Leading Pharma, LLCNDC
69315032005
Classification
Generic
Dosage Form
SOLUTION
Route
AURICULAR (OTIC)
Effective Date
9/23/2026
Active Ingredients
OFLOXACINApproval Type
Generic (ANDA)
FDA Application
ANDA217903FDA Approved
1/5/2024
TE Code
AT
On Market Since
3/1/2024
Pharmacological Classes
Price Statistics
The NADAC for OFLOXACIN 0.3% EAR DROPS has been published 122 times since Jun 5, 2024, and over the history we have for it it has declined 19.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1098 per ML |
|---|---|
| All-time high | $1.8131 (Jul 10, 2024) |
| All-time low | $1.0722 (Jul 22, 2026) |
| 52-week high | $1.3628 |
| 52-week low | $1.0722 |
| Median price | $1.3201 |
| Average price | $1.3296 |
| Largest weekly change | +31.1% (Jun 19, 2024) |
| Weeks tracked | 122 |
| Tracking since | Jun 5, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Leading Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
OFLOXACIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Quinolone Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OFLOXACIN 0.3% EAR DROPS?
The current National Average Drug Acquisition Cost (NADAC) for OFLOXACIN 0.3% EAR DROPS, manufactured by Leading Pharma, LLC, is $1.1098 per ML (NDC 69315032005), effective Sep 30, 2026.
How has the price of OFLOXACIN 0.3% EAR DROPS changed over time?
Over the history we have for it, the NADAC for OFLOXACIN 0.3% EAR DROPS has declined 19.7%. It has been tracked across 122 weekly CMS publications since Jun 5, 2024.
What are the highest and lowest recorded NADAC prices for OFLOXACIN 0.3% EAR DROPS?
Since Jun 5, 2024, the NADAC for OFLOXACIN 0.3% EAR DROPS has ranged from a low of $1.0722 (Jul 22, 2026) to a high of $1.8131 (Jul 10, 2024), with a median of $1.3201 per ML.
Are there cheaper alternatives to OFLOXACIN 0.3% EAR DROPS?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OFLOXACIN 0.3% EAR DROPS, is $0.9789 per ML — about 12% below OFLOXACIN 0.3% EAR DROPS.
Who manufactures OFLOXACIN 0.3% EAR DROPS?
OFLOXACIN 0.3% EAR DROPS (NDC 69315032005) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.